KannaSwiss

KannaSwiss GmbH, established in 2014, positioned itself as a key player in the European cannabidiol (CBD) market from its headquarters in Kölliken, Switzerland. The company was co-founded by Ivan Enderli and Corso Serra di Cassano, who was motivated by his personal experience with ulcerative colitis to make the benefits of CBD widely accessible. Boris Blatnik joined the team in 2017 as Chief Strategy Officer and later became CEO, bringing a diverse background in telecommunications, natural resources, and business development to steer the company's rebranding and expansion.

The firm operates on a vertically integrated business model, controlling the entire production process from seed to shelf to ensure product quality. KannaSwiss specializes in producing and supplying a wide array of CBD products, serving both bulk and retail clients. Its business is structured into several divisions, including Health & Wellness, Bulk Sales, and a Medical division under development. The company generates revenue through the sale of bulk CBD isolate and distillate to other businesses and by marketing its own branded consumer products.

KannaSwiss cultivates its organic cannabis in the Swiss highlands and utilizes a commercial ethanol extraction method in its state-of-the-art facility. This process is enhanced by a short-path destination system to increase the concentration and effectiveness of the final product. The company's product portfolio is extensive, including CBD oil, tinctures, flowers, water-soluble drops, transdermal creams, cosmetics, and supplements. A notable achievement was the creation of the world's first legal CBD hash in 2017, available in various concentrations. Seeking to meet diverse consumer needs, KannaSwiss has also focused on developing cannabinoid-enhanced beverages and products tailored for athletes. In 2019, the company secured a significant $5.5 million investment from Altitude Investment Management to scale its extraction operations, expand production capabilities, and pursue ISO 9000 and GMP certifications. However, according to a PitchBook report, the company later entered bankruptcy liquidation proceedings as of April 25, 2025.

Keywords: KannaSwiss, CBD, cannabidiol, Switzerland, Ivan Enderli, Boris Blatnik, CBD isolate, CBD distillate, vertical integration, cannabis extraction, ethanol extraction, CBD products, hemp oil, CBD topicals, CBD hash, bulk CBD, European cannabis market, wellness products, cannabis cultivation, seed to shelf, medical marijuana